LANSING — Michigan Gov. Gretchen Whitmer said Wednesday the state is working to expand access to therapeutic treatments for COVID-19 and its variants, as Michigan continues to face the highest case rates in the U.S.
Whitmer and Dr. Joneigh Khaldun, the state's chief medical executive, announced the state is making efforts to expand access to monoclonal antibody (mAb) treatments. The treatments were used to treat former President Donald Trump when he contracted COVID-19 in 2020.
No details on the expansion plan were announced Wednesday. Officials said the state was working to access mAb treatments produced by pharmaceutical manufacturers Eli Lilly and Regeneron, specifically.